Elucidating GPCR Functional Selectivity: Novel Opportunities for Drug Development

The New York Academy of Sciences
Tuesday, September 30, 2014
Explore the paradigm of GPCR ligand bias in the brain and the use of dopamine receptor agonists in the treatment of psychiatric disorders.


New Frontiers in the Neurobiology of Mental Illness

The New York Academy of Sciences
Friday, October 10, 2014
Explore the translation of neuroscientific breakthroughs into therapies for mental illnesses such as schizophrenia, depression, fear and anxiety disorders, and autism. Free event—Advance registration required.


Pharmacologic Resolution of Inflammation as a Novel Therapeutic Approach

The New York Academy of Sciences
Tuesday, October 28, 2014
As Alzheimer’s disease is now recognized as an ‘inflammatory disease’, inflammatory macrophages offer opportunities for resolution-based pharmacology.


Gene Network Changes in Alzheimer’s Disease: Potential Points for Therapeutic Intervention

The New York Academy of Sciences
Monday, November 03, 2014
Next-generation sequencing of Alzheimer’s disease progression reveals gene network changes within microglial pathways, the understanding of which is critical.


Shaping the Developing Brain: Prenatal through Early Childhood

The New York Academy of Sciences
Tuesday, November 11, 2014
The fifth annual Aspen Brain Forum will highlight educational practices, health and nutrition practices, applied research, and government policy with the potential for enhancing healthy brain development and improving outcomes for at-risk children.


2014 International Neuroethics Society Annual Meeting

AAAS, Washington, DC
Thursday, November 13, 2014
This two-day annual meeting features a public program on Thursday, November 13, “Neuroscience Knowledge and the Robotic Mind,” and several expert panels the following day. Panel topics include the BRAIN Initiative, neuroscience and the courts, and neuroscience and human rights.